安德克萨内特阿尔法用于埃多克萨班逆转和相关的血栓结晶学术手术肺栓塞术的变化
Yu Fukuda1, Koichi Yoshinaga2, Shin Kondo1
1Department of Anesthesiology and Critical Care Medicine, Jichi Medical University Saitama Medical Center, Saitama, JPN.
Cureus
|July 15, 2024
概括
安德克萨内特阿尔法有效地逆转了埃多克萨班.
科学领域:
- 心脏病学 心脏病学
- 血液学 血液学 血液学
- 麻醉学 麻醉学
背景情况:
- 直接口服抗凝剂 (DOAC),如埃多克萨班,越来越多地使用,但在心脏手术期间控制出血方面存在挑战.
- 肝素耐药性和缺乏护理点监测使得使用逆转药物 (如安德克萨尼特阿尔法) 在心肺旁路 (CPB) 中变得复杂.
相关概念视频
Anticoagulant Drugs: Low-Molecular-Weight Heparins
672
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
672
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
152
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
152


